Price
$31.00
Decreased by -2.64%
Dollar volume (20D)
2.35 M
ADR%
4.78
Earnings report date
Jul 30, 2024
Shares float
15.09 M
Shares short
229.11 K [1.52%]
Shares outstanding
23.88 M
Market cap
760.25 M
Beta
0.47
Price/earnings
25.68
20D range
28.51 35.81
50D range
28.51 40.65
200D range
28.51 46.84

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience.

Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools.

Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership.

National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 8, 24 0.27
Decreased by -5.25%
-
Feb 14, 24 0.36
Increased by +33.33%
-
Nov 8, 23 0.32
Decreased by -3.03%
-
Aug 2, 23 0.29
Decreased by -12.12%
-
May 3, 23 0.28
Decreased by -17.65%
-
Feb 15, 23 0.27
Decreased by -28.95%
-
Nov 2, 22 0.33
Decreased by -13.16%
-
Aug 2, 22 0.33
Decreased by -5.71%
-
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 35.31 M
Decreased by -3.18%
6.36 M
Decreased by -8.70%
Increased by +18.00%
Decreased by -5.70%
Dec 31, 23 38.00 M
Decreased by -0.37%
8.86 M
Increased by +33.38%
Increased by +23.31%
Increased by +33.89%
Sep 30, 23 37.95 M
Increased by +0.67%
7.88 M
Decreased by -5.04%
Increased by +20.76%
Decreased by -5.68%
Jun 30, 23 36.16 M
Decreased by -3.03%
7.27 M
Decreased by -12.61%
Increased by +20.11%
Decreased by -9.87%
Mar 31, 23 36.47 M
Decreased by -5.12%
6.96 M
Decreased by -18.44%
Increased by +19.09%
Decreased by -14.04%
Dec 31, 22 38.14 M
Decreased by -0.40%
6.64 M
Decreased by -31.03%
Increased by +17.41%
Decreased by -30.75%
Sep 30, 22 37.69 M
Decreased by -0.20%
8.29 M
Decreased by -14.07%
Increased by +22.01%
Decreased by -13.90%
Jun 30, 22 37.29 M
Increased by +2.38%
8.32 M
Decreased by -6.95%
Increased by +22.32%
Decreased by -9.12%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY